Prevalence of body dysmorphic disorder in a community sample of women

被引:126
作者
Otto, MW
Wilhelm, S
Cohen, LS
Harlow, BL
机构
[1] Massachusetts Gen Hosp, Cognit Behav Therapy Program, Dept Psychiat, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA
关键词
D O I
10.1176/appi.ajp.158.12.2061
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
objective: In a large population-based study, the authors examined the prevalence and correlates of body dysmorphic disorder, a debilitating and chronic condition characterized by an imagined defect in appearance. Method: Rates and diagnostic correlates of body dysmorphic disorder were examined by using data from the Harvard Study of Moods and Cycles. This study used in-person structured clinical interviews to characterize the diagnostic status of a population-based, cross-sectional sample of 318 depressed and 658 nondepressed women between the ages of 36 and 44 who were selected from seven Boston metropolitan area communities. Results: The presence of body dysmorphic disorder was significantly associated with the presence of major depression and anxiety disorders. The authors estimated the overall point prevalence of body dysmorphic disorder as 0.7% in women in this age range in the community. Conclusions: The authors found that the presence of body dysmorphic disorder was linked to the presence of major depression and anxiety disorders, which is similar to findings in clinical studies. Their estimate of the point prevalence of body dysmorphic disorder is consistent with data from a community-based sample of Italian women and suggests a prevalence similar to that of other serious psychiatric disorders in women (e.g., schizophrenia and drug abuse and dependence). These prevalence data encourage the further development of treatment options for this debilitating condition.
引用
收藏
页码:2061 / 2063
页数:3
相关论文
共 23 条
  • [1] BLAZER DG, 1994, AM J PSYCHIAT, V151, P979
  • [2] BRAWMANMINTZER O, 1995, AM J PSYCHIAT, V152, P1665
  • [3] CASH TF, 1986, PSYCHOL TODAY, V20, P30
  • [4] Epidemiology of somatoform disorders: A community survey in Florence
    Faravelli, C
    Salvatori, S
    Galassi, F
    Aiazzi, L
    Drei, C
    Cabras, P
    [J]. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 1997, 32 (01) : 24 - 29
  • [5] First MB, 2002, STRUCTURED CLIN INTE
  • [6] BODY DYSMORPHIC DISORDER - IMPLICATIONS FOR ITS VALIDITY AS A DSM-III-R CLINICAL SYNDROME
    FITTS, SN
    GIBSON, P
    REDDING, CA
    DEITER, PJ
    [J]. PSYCHOLOGICAL REPORTS, 1989, 64 (02) : 655 - 658
  • [7] Prevalence and predictors of depressive symptoms in older premenopausal women - The Harvard Study of Mood and Cycles
    Harlow, BL
    Cohen, LS
    Otto, MW
    Spiegelman, D
    Cramer, DW
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1999, 56 (05) : 418 - 424
  • [8] Clomipramine vs desipramine crossover trial in body dysmorphic disorder - Selective efficacy of a serotonin reuptake inhibitor in imagined ugliness
    Hollander, E
    Allen, A
    Kwon, J
    Aronowitz, B
    Schmeidler, J
    Wong, C
    Simeon, D
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1999, 56 (11) : 1033 - 1039
  • [9] BODY DYSMORPHIC DISORDER
    HOLLANDER, E
    COHEN, LJ
    SIMEON, D
    [J]. PSYCHIATRIC ANNALS, 1993, 23 (07) : 359 - 364
  • [10] Maintenance of remission following cognitive behavior therapy for panic disorder: Possible deleterious effects of concurrent medication treatment
    Otto, MW
    Pollack, MH
    Sabatino, SA
    [J]. BEHAVIOR THERAPY, 1996, 27 (03) : 473 - 482